Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
bioAffinity Technologies, Inc. | Secretary, EVP, Gen. Counsel | Common Stock | 46.1K | $119K | $2.58 | Apr 4, 2024 | Direct |
bioAffinity Technologies, Inc. | Secretary, EVP, Gen. Counsel | Stock Option (right to buy) | 0 | Apr 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BIAF | bioAffinity Technologies, Inc. | Apr 4, 2024 | 3 | $324 | 4 | Apr 24, 2024 | Secretary, EVP, Gen. Counsel |
BIAF | bioAffinity Technologies, Inc. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Secretary, EVP, Gen. Counsel |
BIAF | bioAffinity Technologies, Inc. | Nov 17, 2022 | 1 | $0 | 4 | Dec 5, 2022 | Secretary, EVP, Gen. Counsel |
BIAF | bioAffinity Technologies, Inc. | Aug 29, 2022 | 0 | $0 | 3 | Dec 5, 2022 | Secretary, EVP, Gen. Counsel |